Tarsus Pharmaceuticals (TARS) PT Raised to $95 at Oppenheimer
Tweet
Share
E-mailGet Alerts TARS Hot Sheet
Price: $75.96 +2.25%
Rating Summary:
11 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Rating Summary:
11 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Join SI Premium – FREE
Oppenheimer analyst Suraj Kalia raised the price target on Tarsus Pharmaceuticals (NASDAQ: TARS) to $95.00 (from $75.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Goldman Sachs Assumes Tarsus Pharmaceuticals (TARS) at Buy
- Isuzu Motors Limited (7202:JP) (ISUZY) PT Lowered to JPY2,600 at UBS
- Meta Platforms Inc. (META) PT Raised to $995 at Tigress Financial Partners
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
